Avir at Beaumont: Possible Drug Diversion Found - TX
The medication was Lorazepam, a controlled benzodiazepine used to treat anxiety. For Resident 1, it was prescribed and stocked. Someone was signing it out. But when inspectors reviewed the July and August 2025 medication administration records, the entries weren't there. The controlled medication count sheet showed the drug leaving inventory. The MARs showed nothing.
The gap between those two documents is the center of this inspection.
The Assistant Director of Nursing reviewed both records during an interview with inspectors on August 19. She said she could not verify the resident had ever received the medication based on what the MARs showed for either month. Then she said what the records implied: "It could possibly be a drug diversion."
The Administrator and the Director of Nursing reviewed the same paperwork. They looked at the count sheet. They looked at the MARs. They looked at the nurse notes, which also contained no documentation that the medication had been given on the dates it was signed out. Their conclusion matched the ADON's. The adverse outcome, they said, could be drug diversion.
None of them disputed what the records showed. The medication was signed out. The medication was not documented as administered. The nurse notes didn't fill the gap.
What that means for Resident 1 is not stated in the inspection report. Whether the resident went without a prescribed medication for days or weeks, whether anyone noticed, whether the resident experienced anxiety or distress without it — the report doesn't say. What it says is that someone signed a controlled substance out of inventory across two calendar months and left no trail of it reaching the person it was prescribed for.
Lorazepam is a Schedule IV controlled substance. It does not leave a facility's count sheet without someone's signature. That signature creates a record of accountability — a claim that the drug was administered to a specific resident at a specific time. When the MAR doesn't reflect that administration, one of two things is true: the documentation failed, or the medication never reached the resident.
The ADON, the Administrator, and the DON all reviewed the evidence together and did not land on documentation failure as their explanation.
The inspection was conducted as a complaint investigation. Inspectors cited the deficiency under F0755, which covers medication management for controlled substances. The level of harm was categorized as minimal harm or potential for actual harm, affecting few residents.
That classification reflects regulatory language, not the full weight of what the records show. A controlled medication disappearing from inventory without any corresponding record of administration, across two months, with the facility's own management team using the phrase "drug diversion" to describe what may have happened — that is not a paperwork problem.
If someone was taking Lorazepam that belonged to a resident, that resident may have gone without a prescribed medication without anyone in the building knowing. The count sheet said it was given. The MAR said nothing. The nurse notes said nothing. The resident had no way to report the discrepancy.
The inspection report ends where it began: with two records that don't match, and a management team that acknowledged the mismatch and named the most likely explanation themselves.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Avir At Beaumont from 2025-08-19 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: This article is based on inspection data downloaded directly from the Centers for Medicare & Medicaid Services (CMS) via Medicare.gov. CMS releases inspection reports in bulk; we publish the findings as documented by state surveyors in the official Form CMS-2567 Statement of Deficiencies.
Plan of correction: The CMS report we receive does not include the facility's plan of correction. Facilities submit plans of correction separately to state survey agencies and those responses may not be reflected in CMS data at the time of publication. The absence of a plan of correction in our data does not mean one was not filed. Readers who want information about corrective steps taken are encouraged to contact the facility directly or their state survey agency.
Corrections may have occurred: Inspection reports reflect conditions observed on the date of the survey. Facilities may have implemented corrections, staffing changes, additional training, or other remediation since the report was issued. We report what CMS provides and encourage readers to seek current information from the facility.
Editorial process: Inspection findings are extracted from CMS source documents and synthesized using AI, reviewed for factual accuracy against the original report by our editorial team.
Corrections: We strive for accuracy in everything we publish. If you believe any fact in this article is incorrect, please contact us with details, and we will review and correct it promptly.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: October 15, 2026 · Our methodology
Avir at Beaumont in Beaumont, TX was cited for violations during a health inspection on August 19, 2025.
The medication was Lorazepam, a controlled benzodiazepine used to treat anxiety.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.